Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
enzyme
gene editing
life sciences
national blog main
national top stories
san francisco blog main
san francisco top stories
2
×
agios therapeutics
base editing
boston
boston blog main
boston top stories
branden moriarty
broad institute
cas13
clinical study
crispr therapeutics
crispr-cas9
data
david liu
disease
dna
editas medicine
editor
editr
feng zhang
gag
genome editing
harvard university
hunter syndrome
ids
intellia therapeutics
john evans
keith joung
massachusetts general hospital
mps ii
mucopolysaccharidosis ii
nicole gaudelli
precise
What
editing
2
×
gene
medicine
2
×
therapeutics
2
×
beam
benefit
cas
crispr
editas
editor
founders
going
gotten
harvard
humans
isn't
jump
landmark
little
mass
morning
nasdaq
phase
precise
reported
reports
results
sangamo
scientists
spotlights
startup
study
trial
u.s
university
version
Language
Current search:
xconomy.com
×
medicine
×
therapeutics
×
editing
×
" san francisco top stories "
×
@xconomy.com
5 years ago
In Landmark Gene-Editing Study, Sangamo Reports Little Benefit
@xconomy.com
6 years ago
Beam Therapeutics Spotlights CRISPR 2.0 with Precise Gene Editor, $87M